(Q46736571)

24 December 2017

title

Effects of the NMDA antagonist ketamine on task-switching performance: evidence for specific impairments of executive control (English)

1 reference

24 December 2017

1

Gijsbert Stoet

1 reference

24 December 2017

author name string

Lawrence H Snyder

series ordinal

2

1 reference

24 December 2017

language of work or name

English

0 references

publication date

5 October 2005

1 reference

24 December 2017

published in

Neuropsychopharmacology

1 reference

24 December 2017

volume

31

1 reference

24 December 2017

issue

8

1 reference

24 December 2017

page(s)

1675-1681

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300930

exact match

0 references

cites work

"Reverse" Stroop effect in the performance of schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Increased stroop facilitation effects in schizophrenia are not due to increased automatic spreading activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Ketamine-induced distractibility: An oculomotor study in monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Assessment of the dysexecutive syndrome in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Characteristics of ?anti? saccades in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

The Stroop effect in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Association of symptoms and executive function in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Do schizophrenia patients make more perseverative than non-perseverative errors on the Wisconsin Card Sorting Test? A meta-analytic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Acute Effects of Ketamine on Memory Systems and Psychotic Symptoms in Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Using saccade tasks as a tool to analyze executive dysfunctions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Selective cognitive impairments associated with NMDA receptor blockade in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Assessment of executive dysfunction during activities of daily living in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Executive control and task-switching in monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Task preparation in macaque monkeys ( Macaca mulatta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Single neurons in posterior parietal cortex of monkeys encode cognitive set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Studies of interference in serial verbal reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Ketamine impairs multiple cognitive domains in rhesus monkeys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Are impairments of action monitoring and executive control true dissociative dysfunctions in patients with schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Schizophrenic subjects show deficient inhibition but intact task switching on saccadic tasks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

Antisaccades and task switching: studies of control processes in saccadic function in normal subjects and schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

7 January 2021

Wisconsin Card Sorting Test: an indicator of vulnerability to schizophrenia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

7 January 2021

Task set switching in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

7 January 2021

Executive control function: a review of its promise and challenges for clinical research. A report from the Committee on Research of the American Neuropsychiatric Association.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300930

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300930

1 reference

24 December 2017

PubMed ID

16205773

1 reference

24 December 2017